CFTR and cystic fibrosis: The landscape of cystic fibrosis (CF) is changing, as the highly effective CF transmembrane conductance regulator (CFTR) modulating drug, elexacaftor–tezacaftor–ivacaftor (ETI), is now available for people with CF (pwCF) with at least 1 F508del mutation.